Business Wire

E Ink and Faubel Unveil the Med Label to Revolutionize the Clinical Trial Supply Chain

Del

E Ink® Holdings, "E Ink" (8069.TW), the leading innovator of electronic ink technology and Faubel & Co. Nachf. GmbH, a proven supplier to the pharmaceutical and chemical industry, announced the availability of the Faubel-Med® Label, a smart label for investigational medicinal products. The Med Label features E Ink’s low-voltage film technology, bringing display modules and new system designs to pharmaceutical packaging.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180418005263/en/

The Faubel-Med® Label is a smart label for investigational medicinal products that uses an E Ink dis ...

The Faubel-Med® Label is a smart label for investigational medicinal products that uses an E Ink display. (Photo: Business Wire)

The Med Label is a combination of an ePaper display and a booklet label that is integrated with radio-frequency identification (RFID) technology to allow pharmaceutical packaging to be updated on demand. The Med Label features a segmented bi-stable E Ink display that can provide expiry updates - even on a sealed kit. This digital solution provides pharmaceutical companies an alternative to relabeling whenever stability data changes, allowing for considerable time and cost savings to international clinical trials.

“The Med Label is a breakthrough product that makes the handling of investigational medicinal products in clinical trial supply chains so much easier,” said Konrad Zachman, Head of Production for New Technologies at Faubel. “As we see a continuous growth in biologic products that require frequent updates on stability data, the Med Label emerges as a cost-effective, highly-efficient smart label that meets the demands of present and future compliance requirements.”

Thanks to E Ink’s ePaper solution, Faubel is expanding its service offerings to provide connected labels with RFID and ePaper technology. Furthermore, this innovation enables the pharmaceutical industry to go digital using valuable tools such as software and real-time reporting, among others. “We believe this is a game changer that will transform clinical trials, saving the industry time and money,” said Frank Jäger, Managing Director at Faubel.

The Med Label is equipped with a battery-free, always-on ePaper display and an RFID tag. It facilitates on-demand label updates for expiry dates at the clinical depot site and provides real time reporting and documentation that meet compliance requirements.

“E Ink’s smart packaging solutions are at the forefront of pharmaceutical packaging innovation,” said Paul Apen, Chief Strategy Officer at E Ink. “Adding displays to pharma packaging requires thin and flexible displays that are also low-power. Our ePaper displays are perfect for this application given their thin, low voltage properties, as well as easy readability, contrast and wide viewing angle.”

E Ink’s new low-voltage film uses roughly 5v compared to the typical 15v driving voltage for electronic paper displays, which decreases the power required for label updates and speeds the update process.

“We are thrilled to partner with Faubel to create a product that will help the pharmaceutical industry take advantage of the digital resources at its disposal,” said FY Gan, Executive Vice President of Sales Center at E Ink. “The potential to enhance and simplify clinical trials is endless; we’re excited to collaborate with industry leaders like Faubel to provide system integration capability for not only the pharmaceutical industry in a total solution, but a wide range of smart packaging applications that deliver the best customer experience of using e-paper for digital transformation.”

The Med Label is currently available for commercial use. To learn more about the solution, visit: http://www.faubel.de/en/pharma-services/clinical-trials/med-label.html.

About Faubel:

The Faubel Group is a global supplier of functional labels with various locations in Europe, the USA and Asia. The Faubel Pharma Services business unit has positioned itself as an innovation and quality leader in clinical trial labeling for multinational trials.

Faubel Pharma Services deals with label design, the production of labels of up to 113 pages, the overprinting of pre-produced bulk goods with variable data as well as with routing. In addition to these established services, the multi-service provider develops individual packaging concepts that are able to mask investigational medicinal products and to withstand temperatures down to -196°C.

With its Faubel-Med® Label, the company offers a unique label whose contents can be updated digitally. When stability data changes, the Med Label replaces re-labeling and provides the necessary flexibility for study pooling.

About E Ink Holdings

E Ink Holdings Inc. (8069.TWO), based on technology from MIT’s Media Lab, has transformed and defined the eReader market and is redefining the signage, architecture and design, mobile, wearable and retail markets with its ePaper technology, enabling a new multi-billion dollar market in less than 10 years. Its corporate philosophy aims to deliver revolutionary products, user experiences and environmental benefits through advanced technology development. This vision has led to its continuous investments in the field of ePaper displays as well as expanding the use of its technologies into a number of other markets and applications including smart packaging and fashion. Its Electrophoretic Display products make it the worldwide leader for ePaper. Its Fringe Field Switching (FFS) technologies are a standard for high-end LCD displays and have been licensed to all major liquid crystal display makers in the world. Listed in Taiwan's Taipei Exchange (TPEx) and the Luxembourg market, E Ink Holdings is now the world's largest supplier of ePaper displays. For more information please visit www.eink.com.

Contact information

Faubel:
Faubel & Co. Nachfolger GmbH
Miriam Hüther, +49 5661 7309-219
m.huether@faubel.de
or
E Ink:
Racepoint Global
Lauren Ginsberg, +1 617-624-3254
lginsberg@racepointglobal.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IDEMIA Provides Subscription Management Platform to dtac in Thailand to Offer eSIM Connected Watches to All Its Subscribers.14.12.2018 03:30Pressemelding

IDEMIA, the global leader in Augmented Identity, has been selected by dtac, the leading mobile operator in Thailand, to offer connectivity on eSIM connected watches. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005934/en/ Credits : IDEMIA IDEMIA’s Subscription Management platform (or remote SIM provisioning) is the technology that remotely connects the embedded SIM of a smartwatch to dtac’s network without inserting a physical SIM card. Indeed, the IDEMIA Subscription Manager is a server which securely manages the lifecycle of mobile subscriptions and profiles for eSIM-ready consumer devices and wearables. This solution is compliant with the latest GSMA (Global System for Mobile Communications Association) standards to ensure global interoperability and, thanks to the scalability of the platform, the operator will be able to serve up to millions of customers during peak times. dtac subscribers now have the possibilit

CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer13.12.2018 17:46Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending an additional indication to include rucaparib as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. EC approval is anticipated in the first quarter of 2019. Once approved, Rubraca’s indication will expand beyond its initial Marketing Authorization in Europe granted in May 2018 for adult patients with platinum-sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum

Dole Food Company Sells Fresh Cut Business in Sweden and Finland13.12.2018 17:00Pressemelding

Dole Food Company, Inc., announced today an agreement to sell Saba Fresh Cuts AB and Saba Fresh Cuts OY to BAMA International. Saba Fresh Cuts AB—with production facility in Helsingborg Sweden—and Saba Fresh Cuts OY—with production facility in Espoo Finland—are producers of washed and ready-to-eat salads. The companies prepare and sell various fresh-cut salads and vegetables to the retail and foodservice industry in Sweden, Denmark, Finland, Germany and the Baltic States. The sale of Saba Fresh Cuts AB was a necessary condition of the European Commission’s approval of the investment by Total Produce into Dole in July 2018. “I am very pleased with the outcome of this sale in meeting the EU’s requirement,” said Mr. Johan Linden, President and Chief Executive Officer of Dole Food Company, “and I am confident that Saba Fresh Cuts will be in good hands under BAMA’s ownership.” "We are pleased to announce this agreement with Dole for Saba Fresh Cuts. Convenience products and ready-to-eat sal

Thales and Gemalto Are Granted Regulatory Clearance by the Commerce Commission in New Zealand13.12.2018 16:00Pressemelding

Regulatory News: Reference is made to the joint press release by Thales (Euronext Paris: HO) and Gemalto (Euronext Amsterdam and Paris: GTO) dated 27 March 2018 in relation to the launch of the recommended all-cash offer by Thales for all the issued and outstanding shares of Gemalto (the “Offer”), the publication of the Offer Document, and the joint press release of Thales and Gemalto dated 10 August 2018 in relation to the further extension of the Acceptance Period. Terms not defined in this press release will have the meaning as set forth in the Offer Document. Thales and Gemalto announce today that they have received merger control Regulatory Clearance from the Commerce Commission in New Zealand, following Thales’s commitment to divest its general purpose hardware security modules (GP HSM) business globally1 to a suitable purchaser. This clearance is effective immediately. Together with the antitrust clearances obtained in China, Israel, South Africa, Turkey, and for the European Un

Hurricane Electric Becomes First Internet Backbone to Connect to 200 Internet Exchanges around the Globe13.12.2018 15:37Pressemelding

Hurricane Electric, the world’s largest IPv6-native Internet backbone, today announced that it is the first Internet backbone in the world to connect to over 200 unique Internet exchanges. As an early leader in the switch to IPv6, Hurricane Electric now connects to the largest number of networks on the planet for both IPv6 and IPv4 and has been at the forefront of providing high-speed Internet connectivity to organizations throughout the world using:100GE (100 Gigabit Ethernet), 10GE (10 Gigabit Ethernet), and GigE (1 Gigabit Ethernet) connections. As a result of the improved connectivity with these 200 exchanges, customers receive the benefit of lower latency, higher throughput and increased fault tolerance. This reliable connectivity is especially important as global IP traffic continues to increase – Cisco’s Visual Networking Index: Forecast and Trends, 2017–2022 predicts that annual global IP traffic will reach 4.8 zettabytes (ZB) per year by 2022, or 396 exabytes (EB) per month, t

The World's Largest Heritage and Culture Festival to Begin With the Slogan Janadria 33 Faithfulness and Loyalty13.12.2018 15:15Pressemelding

With the support and under the patronage of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz, the 33rd Edition of the National Festival of Heritage and Culture will be held in Janadria for 21 days from Thursday 20th December 2018 to Wednesday 9th January 2019. Organized by the Saudi Ministry of National Guard, the festival is part of the efforts to intensify attention to Saudi heritage, expose it regionally and globally and to promote dialogue among cultures and civilizations on the level of people and nations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005472/en/ The Custodian of the Two Holy Mosques King Salman bin Abdulaziz (Photo: AETOSWire) Janadria is the largest Saudi cultural festival that simulates the history, present and future of Saudi Arabia and the largest event of its kind in the region. Since 1985, it has witnessed extensive Saudi participation, a growing Arab and Gulf presence and an